16,200
Participants
Start Date
May 30, 2024
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
R21Matrix M
A mixture of R21/Matrix M at a dose of 5 μg (for children up to 14 years of age) or 10 μg ( for individuals ≥ 15 years old) with 50 μg of Matrix-M will be administered monthly over 3 months (one dose per month over 3 months (May, June, and July 2024) plus a booster dose in June 2025.
RECRUITING
MRC Unit The Gambia at LSHTM, Fajara
RECRUITING
Clinical Research Unit of Nanoro, Burkina Faso, Nanoro
National Malaria Control Programme, The Gambia
OTHER_GOV
London School of Hygiene and Tropical Medicine
OTHER